TXMD: TherapeuticsMD Inc Company Profile & Statistics

About

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida.

Info & Links

CEO

Marlan D. Walker

Headquarters

951 Yamato Road, Suite 220
BOCA RATON, FL 33431, UNITED STATES

Auditor

GRANT THORNTON LLP

Share holders

Employees

TherapeuticsMD Inc Statistics

Valuation Measures

Market Capitalization²

13.03M

Enterprise Value

7.98M

Enterprise Value/EBITDA(ttm)

-1.59

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

8.82

Price to Book(mrq)

0.52

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-248.56%

Profit Margin(ttm)

-246.89%

Return on Equity(ttm)

-14.08%

Return on Invested Capital(ttm)

-13.97%

Return on Assets(ttm)

-9.61%

Income Statement

Revenue(ttm)

1.60M

Revenue Per Share(ttm)

0.14

Gross Profit(ttm)

1.60M

EBITDA(ttm)³

-5.01M

Net Income Available to Common(ttm)

-3.32M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

1.12

52-Week Change

-55.51%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

11.53M

Dividend Yield

0.00%

Float⁴

11.27M

% Held by Insiders

2.30%

% Held by Institutions

30.74%

Balance Sheet

Total Cash(mrq)

5.05M

Total Cash Per Share(mrq)

0.44

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.03%

Quick Ratio(mrq)

2.03%

Book Value Per Share(mrq)

2.35

Cash Flow

Operating Cash Flow Per Share(ytd)

0.10

Free Cash Flow(ytd)

1.15M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

TXMD

TherapeuticsMD Inc

TherapeuticsMD Inc Profile